InvestorsHub Logo

homeslice10

04/30/14 4:39 PM

#65438 RE: MightyLion #65437

I think your post is a foul ball. Its pretty clear in the amended 10K that shareholder rights are fully addressed and in the standard operating procedure, dating back to 2013. I think current management is doing that to inform shareholders that they are not going to be exploited in any way that would be abnormal, and for you to insinuate that bankruptcy is an option when its not even remotely reasonable is just a disguised attempt to create fear, in my opinion. The shareholders' concerns are in fact addressed and Myles is doing a great job providing that in company writing (10K).

As for the JV and uplist, what big pharma wouldn't want this in their pipeline?

farviewhill

04/30/14 7:04 PM

#65448 RE: MightyLion #65437

MIGHTY, I can see an announcement of a JV and even a buyout as very likely and possible. These things take a lot of legal time to define and put to paper and to get the respective Boards to aprove, etc.

Sorry but in the case of a JV and immediate uplist, you've lost me. That would be great but ACTC doesn't have the shareholder's approval to get a reverse split price to where it would qualify for any level of uplist to my knowledge, nor any revenue/cash, which I believe is one of a number of conditions at all levels?
A !:100 apprved RS wouldn't get us anywhere near an acceptable share price. What am I missing, unless the company has the ability to take some type of unilateral, non-shareholder approved action with the share price/shares outstanding to bring an uplist about?
Please explain how the uplist would work, without coming back to the shareholders for new approval, say 1;5000 RS or something like that?
thanks

It all comes down, imo, to satisfying upcoming debt and having finances to begin phase 11 and meet things like other operating expenses. Everything else suggested is nice, but just silliness, imo. It's called money.

One very nice thing is ACTC owns a lot of IP, not Lanza and Lanza must want a financially viable ACTC to survive, especially where he has the dollars and the power to be his own boss and not swallowed up by some behemoth pharma if that's in the cards.